118. VALIDATION OF THE RENAL RISK SCORE FOR ANCA-ASSOCIATED GLOMERULONEPHRITIS
Emma van Daalen(University Medical Center Utrecht), Ingeborg M. Bajema(University Medical Center Groningen), Maria A.C. Wester Trejo(Leiden University Medical Center), Wladimir Szpirt(University of Copenhagen), Jan A. Bruijn(Leiden University), Zdenka Hrušková(Charles University), Willem Jan W. Bos(St. Antonius Ziekenhuis), Ron Wolterbeek(Leiden University Medical Center), Renate Kain(Medical University of Vienna), Eva Honsová(Institute of Clinical and Experimental Medicine), Kensuke Joh(Jikei University School of Medicine), M Ball(Medical University of Vienna), Marek Kollár(Institute of Clinical and Experimental Medicine), Xavier Puéchal(Université Paris Cité), Franco Ferrario(Azienda Ospedaliera San Gerardo), Steven Salvatore(Weill Cornell Medicine), Kristine Lindhard(Herlev Hospital), Vladimı́r Tesař(Charles University), Suzanne Wilhelmus(Leiden University Medical Center), Yayoi Ogawa, Annelies E. Berden(Maasstad Ziekenhuis), Laure‐Hélène Noël(Délégation Paris 5), Andreas Kronbichler(Innsbruck Medical University), Tomoyoshi Kimura(Japan Community Healthcare Organization), Arda Göçeroǧlu(Leiden University Medical Center)
Cited by 0
Related Papers
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
|Arthritis & Rheumatism|2012|6.6k
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
|Translational research|2020|2.3k
The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited
|Journal of the American Society of Nephrology|2004|2k
Pathologic Classification of Diabetic Nephropathy
|Journal of the American Society of Nephrology|2010|1.7k